IRX
Health Care Equipment & Services
Inhalerx
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 16 June 2025
- Reported shorts
- 5.7K
- Shares on issue
- 213.448M
Inhalerx (IRX) company profile
Profile, insiders and operations
Company
AI-generated research profile of Inhalerx
pharmaceuticals
cannabinoids
drug-device
pain management
mental health
Inhalerx is an Australian healthcare company focused on developing medicinal cannabinoid drug-device products. They aim to address unmet medical needs in the pain management and mental health sectors by creating unique delivery methods for cannabinoid-based medications.
Director trades
10 trades recorded
IRX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required